Skip to main content
OpenTrials

Clinical trial condition

Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Explore clinical trials studying Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Study availability and eligibility vary by location and protocol.

11 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified trial results

Active, Not Recruiting

Zanubrutinib and CAR T-cell Therapy for the Treatment of Recurrent or Refractory Aggressive B-cell Non-Hodgkin's Lymphoma or Transformed Indolent B-cell Lymphoma

NCT05202782

Conditions
Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation, EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +27 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions